跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,540 条关于
“CSM-101”
全部
14,540
临床试验
7,013
药物
5,463
机构
64
资讯
2,000
去年
Casma Therapeutics Nominates First-in-Class TRPML1 Agonist CSM-101 for Parkinson's Disease Treatment
2年前
Chemomab Secures Global Patent Protection for CM-101 Antibody Targeting Primary Sclerosing Cholangitis
5个月前
High-Dose Niacin Shows Promise in Glioblastoma: Early Trial Reports 28% Improvement in Disease Progression
去年
Endeavor BioMedicines' ENV-101 Shows Promise in Reversing Idiopathic Pulmonary Fibrosis in Phase II Trials
去年
Galimedix Therapeutics Initiates Phase 2 Trial of GAL-101 Eye Drops for Dry AMD
2年前
FDA Clears IND for Arbor Biotechnologies' ABO-101 Gene-Editing Therapy for Primary Hyperoxaluria Type 1
去年
Siren Biotechnology's SRN-101 Receives FDA Designations for High-Grade Gliomas
去年
Beckley Psytech Announces Positive Results for ELE-101 in Depression Trial
去年
MAIA Biotechnology's THIO-101 Shows Promise in Advanced NSCLC
去年
TTI-101 Shows Promise in Advanced Cancer Treatment by Targeting STAT3
第 1 页,共 200 页
上一页
下一页